News Search Results
Apr 02, 2026, 07:00 ET National DCP Announces 2026 Board of Directors Officers
Chairman and Secretary throughout his long tenure and has chaired numerous board committees.Neal Faulkner, Secretary - Representing Series B, Faulkner is a Founding Board member of National DCP. He has been a Dunkin' franchisee since 2000, serving as the President of a team that operates
More news about: National DCP, LLC
Apr 01, 2026, 20:05 ET INOVIO Announces Proposed Public Offering
cancer, and infectious diseases, today announced that it intends to offer and sell shares of its common stock and accompanying Series A warrants and Series B warrants to purchase shares of its common stock (or pre-funded warrants to purchase its common stock in lieu thereof), in an underwritten public offering.
More news about: INOVIO Pharmaceuticals, Inc.
Apr 01, 2026, 08:00 ET Sona Raises $45M Series B to Bring AI to the Frontline Economy
Sona has raised $45 million in Series B funding led by N47, with participation from existing investors Felicis, Northzone, Gradient, and Italian Founders Fund, bringing its total funding
More news about: Sona
Mar 31, 2026, 12:44 ET Ericsson's Annual General Meeting 2026
authorization for the Board of Directors to, on one or several occasions prior to the AGM 2027, decide on the purchase of the Company's own shares of series B. The number of shares purchased must at no time result in the Company's holding exceeding 10 percent of all the shares in the Company. The purchases
More news about: Ericsson
Mar 31, 2026, 12:41 ET Ericsson's Annual General Meeting 2026
authorization for the Board of Directors to, on one or several occasions prior to the AGM 2027, decide on the purchase of the Company's own shares of series B. The number of shares purchased must at no time result in the Company's holding exceeding 10 percent of all the shares in the Company. The purchases
More news about: Ericsson
Mar 31, 2026, 09:00 ET Monarch Quantum Surpasses $100M in Capital and Contracts with $55M Growth Round to Scale Quantum Photonics Infrastructure
industry, accelerate discovery, and drive global progress. Headquartered in Copenhagen, Denmark, the fund invests stage-agnostically from Seed to Series B across the full quantum stack—quantum computing, sensing, and communications - targeting enabling technologies, full-stack hardware solutions, and
More news about: Monarch Quantum
Mar 31, 2026, 08:00 ET Ambrosia Biosciences Announces $100 Million Oversubscribed Series B Financing to Advance Novel Small Molecule Cardiometabolic Pipeline
March 31, 2026 /PRNewswire/ -- Ambrosia Biosciences Inc. ("Ambrosia") today announced a $100 million oversubscribed Series B financing.
More news about: Ambrosia Biosciences
Mar 31, 2026, 07:25 ET New number of votes in AB Volvo
conversion of a total of 745,007 Series A shares to a total of 745,007 Series B shares. The conversions were implemented with the support of the opportunity for Series A shareholders to request conversion of Series A shares to Series B shares which was entered in the Articles of Association at the 2011
More news about: AB Volvo
Mar 30, 2026, 21:00 ET EPG Adds Over US$100 Million in Series B+ Financing, Expanding Strategic Backing for Global AI Data Center Growth
2026 /PRNewswire/ -- EPG has closed over US$100 million in Series B+ financing led by Decarbonization Partners, a joint venture between BlackRock and Temasek, Alibaba Cloud, and other strategic investors. The round builds on the company's Series B financing completed earlier this year and further strengthens
More news about: EPG Singapore Pte Ltd
Mar 30, 2026, 21:00 ET EPG Adds Over US$100 Million in Series B+ Financing, Expanding Strategic Backing for Global AI Data Center Growth
2026 /PRNewswire/ -- EPG has closed over US$100 million in Series B+ financing led by Decarbonization Partners, a joint venture between BlackRock and Temasek, Alibaba Cloud, and other strategic investors. The round builds on the company's Series B financing completed earlier this year and further strengthens
More news about: EPG Singapore Pte Ltd
Mar 30, 2026, 12:00 ET CREATE WELLNESS ANNOUNCES SIGNIFICANT GROWTH CAPITAL ROUND FROM LEADING CPG INVESTORS
the company behind the world's leading creatine gummy, today announced it has raised $20 million in growth capital. Create plans to use the Series B funding to accelerate its next phase of growth, including expanding retail distribution, investing in consumer education, advancing product innovation,
More news about: Create Wellness
Mar 30, 2026, 11:06 ET Hoverfly Technologies Enters Drone Components Industry with "Hoverfly Motors - Powered by KRM"
Hoverfly's Series B round in October 2025, designates KRM as the Exclusive Manufacturer for Hoverfly's core propulsion components.The "Hoverfly Motors — Powered
More news about: Hoverfly Technologies Inc.
Mar 30, 2026, 07:45 ET PLEOPHARMA, INC. to Present at the Centri Capital Conference in New York
board of directors who collectively have produced multiple high value exits, >50 worldwide product approvals, and 100+ INDs. PleoPharma closed on a Series B financing round of $36M in the fall of 2025 and has raised over $60M since it was founded in 2019.For more information on PleoPharma Inc.,
More news about: PleoPharma, Inc
Mar 27, 2026, 04:43 ET A Tazapay arrecadaria US$ 36 milhões em financiamento total da Série B para ampliar os trilhos de pagamento de próxima geração globalmente; Circle Ventures lidera a extensão
[email protected] Foto: https://mma.prnewswire.com/media/2943051/Series_B_Tazapay.jpgLogotipo: https://mma.prnewswire.com/media/2737510/Tazapay_Logo.jpg
More news about: Tazapay
Mar 27, 2026, 04:31 ET Tazapay recauda un total de 36 millones de dólares en una ronda de financiación de serie B para expandir sus sistemas de pago de última generación a nivel mundial; Circle Ventures lidera la ronda
[email protected] Foto: https://mma.prnewswire.com/media/2943051/Series_B_Tazapay.jpgLogotipo: https://mma.prnewswire.com/media/2737510/Tazapay_Logo.jpg
More news about: Tazapay
Mar 26, 2026, 11:56 ET Following record Series B, Lucidya launches Enterprise AI Agent Platform as it enters next phase of regional expansion.
RIYADH, Saudi Arabia, March 26, 2026 /PRNewswire/ -- Following its record-breaking USD $30 million Series B funding round in 2025, the largest AI investment at the time in MENA, Lucidya, the AI-native Customer Experience Management (CXM) platform, announced
More news about: Lucidya
Mar 26, 2026, 10:03 ET Notice of Annual General Meeting in Securitas AB
Period") have to either (i) purchase Series B shares in the market and nominate such shares to LTI 2026/2028, (ii) nominate Series B shares vested in previous incentive programs, (iii) nominate Series B shares currently vesting in LTI 2023/2025, or (iv) nominate Series B shares nominated in LTI 2023/2025[1]
More news about: Securitas
Mar 26, 2026, 10:00 ET Cents Raises $140 Million from Sumeru Equity Partners to Support and Drive Innovation for Laundry SMBs
laundry industry, today announced the close of a $140 million Series C round led by Sumeru Equity Partners ("Sumeru") with additional investment from Series B lead Camber Creek. The raise marks the largest single software investment in the laundry vertical to date and accelerates Cents' mission to bring
More news about: Cents
Mar 26, 2026, 09:55 ET Notice of Annual General Meeting in Securitas AB
Period") have to either (i) purchase Series B shares in the market and nominate such shares to LTI 2026/2028, (ii) nominate Series B shares vested in previous incentive programs, (iii) nominate Series B shares currently vesting in LTI 2023/2025, or (iv) nominate Series B shares nominated in LTI 2023/2025[1]
More news about: Securitas
Mar 26, 2026, 09:00 ET Blossom Health Announces $20M to Bring AI Operating System to Psychiatrists and Patients Nationwide
regionally focused early-stage funds across the U.S., Europe, Asia, and Latin America, as well as its Global Growth Fund, which backs companies from Series B and beyond. The size and locations of these funds allow the firm to see local trends up close, meet winning founders, and lead rounds at every stage.
More news about: Blossom Health
Mar 26, 2026, 08:50 ET Lunai Bioworks Executes $20M Strategic Transaction at Fixed $1.50 Conversion, Acquiring BBB Delivery Platform for CNS Alzheimer's Therapies with Broad CNS Delivery Applications
The transaction is structured as Series B Convertible Preferred at a fixed conversion price of $1.50 per share, subject to a 19.9% beneficial ownership limitation. The structure contains no
More news about: Lunai Bioworks Inc.
Mar 26, 2026, 08:20 ET Imagine Pediatrics Releases First Annual Impact Report Demonstrating Proven Outcomes in Pediatric Value-Based Care
$67 million Series B funding round. As Imagine Pediatrics continues expanding its partnerships and geographic reach, the company remains focused on delivering measurable
More news about: Imagine Pediatrics
Mar 26, 2026, 08:00 ET IceCure Announces Pricing of $4.0 Million Registered Direct Offering and Concurrent Private Placement
placement, IceCure will issue and sell unregistered Series B warrants to purchase up to 8,000,000 ordinary shares (the "Series B Warrants") and Series C warrants to purchase up to 8,000,000 ordinary shares (the "Series C Warrants," and together with the Series B Warrants, the "Warrants"). The Warrants will
More news about: IceCure Medical
Mar 26, 2026, 07:30 ET Pinnacle Medicines, a Pioneer of Oral Peptide Therapeutics, Announces Oversubscribed $89 Million Series B Financing to Advance Pipeline into Clinical Trials
development of oral peptide therapeutics using proprietary AI and physics-based platforms, today announced the closing of an oversubscribed $89 million Series B financing. The round was co-led by LAV and Foresite Capital, with participation from Quan Capital, Hankang Capital, RA Capital Management, Logos Capital
More news about: Pinnacle Medicines
Mar 26, 2026, 07:00 ET Opus1 Names Sharad Mohan CEO and Announces Series B Financing from Five Elms Capital
and performing arts schools, today announced the appointment of Sharad Mohan as Chief Executive Officer. The company also announced it has raised a Series B round of financing, underscoring strong investor confidence in Opus1's product, market position, and long-term vision. Founder and former CEO Sam
More news about: Five Elms Capital